Participants with AD (versus normal cognition group) had higher plasma Aβ40, t-tau, and NfL, and lower Aβ42/Aβ40 ratio (demographic-adjusted p < 0.01) (Fig. 3). Here, NEFL is linked to Alzheimer disease.